These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23463483)

  • 21. Potency and recovery characteristics of rocuronium mixed with sodium bicarbonate.
    Lee HJ; Kim KS; Yeon JT; Suh JK; Sung IH; Shin IC
    Anaesthesia; 2010 Sep; 65(9):899-903. PubMed ID: 20608923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults.
    Motamed C; Donati F
    Can J Anaesth; 2000 Mar; 47(3):225-31. PubMed ID: 10730732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of rocuronium 0.3 mg kg(-1) in adult patients with and without renal failure.
    Robertson EN; Driessen JJ; Vogt M; De Boer H; Scheffer GJ
    Eur J Anaesthesiol; 2005 Dec; 22(12):929-32. PubMed ID: 16318664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.
    Kocabas S; Yedicocuklu D; Askar FZ
    Eur J Anaesthesiol; 2008 Nov; 25(11):940-6. PubMed ID: 18538050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous magnesium re-establishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium: a randomised controlled trial.
    Hans GA; Bosenge B; Bonhomme VL; Brichant JF; Venneman IM; Hans PC
    Eur J Anaesthesiol; 2012 Feb; 29(2):95-9. PubMed ID: 22183158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of age on maintenance of intense neuromuscular block with rocuronium.
    Furuya T; Suzuki T; Kashiwai A; Konishi J; Aono M; Hirose N; Kato J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):236-9. PubMed ID: 22236347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular pharmacodynamics of rocuronium in patients with major burns.
    Han T; Kim H; Bae J; Kim K; Martyn JA
    Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomised controlled trial comparing rocuronium priming, magnesium pre-treatment and a combination of the two methods.
    Kim MH; Oh AY; Jeon YT; Hwang JW; Do SH
    Anaesthesia; 2012 Jul; 67(7):748-54. PubMed ID: 22420830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of preoperative oral rehydration on arterial plasma rocuronium concentrations and neuromuscular blocking effects: A randomised controlled trial.
    Ishigaki S; Ogura T; Kanaya A; Miyake Y; Masui K; Kazama T
    Eur J Anaesthesiol; 2017 Jan; 34(1):16-21. PubMed ID: 27606613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Priming rapacuronium: a comparison with rocuronium and mivacurium.
    Steinberg D
    Acta Cient Venez; 2003; 54(2):115-20. PubMed ID: 14976782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperthyroidism patients have shorter onset and duration time of rocuronium than euthyroidism patients.
    Wang YG; Song XJ; Feng SW; Ge YL; Yang JJ; He LL
    J Pharm Pharm Sci; 2007; 10(1):53-60. PubMed ID: 17498394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between rate of administration of an intubating dose of rocuronium and time to 50% and 90% block at the adductor pollicis muscle.
    De Haes A; Eleveld DJ; Wierda JM
    J Clin Monit Comput; 2000; 16(3):219-22. PubMed ID: 12578106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia.
    Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H
    Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of rocuronium administered by continuous infusion in dogs.
    Alderson B; Senior JM; Jones RS; Dugdale AH
    Vet Anaesth Analg; 2007 Jul; 34(4):251-6. PubMed ID: 17490469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.
    Gilliard V; Delvaux B; Russell K; Dubois PE
    Acta Anaesthesiol Belg; 2006; 57(2):157-9. PubMed ID: 16916186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between cardiac output and reversibility of rocuronium-induced moderate neuromuscular block with sugammadex.
    Yoshida F; Suzuki T; Kashiwai A; Furuya T; Konishi J; Ogawa S
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):83-7. PubMed ID: 22103864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous lidocaine has no impact on rocuronium-induced neuromuscular block. Randomised study.
    Czarnetzki C; Lysakowski C; Elia N; Tramèr MR
    Acta Anaesthesiol Scand; 2012 Apr; 56(4):474-81. PubMed ID: 22260297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.